Bioequivalence Protocols: In vivo/ In vitro studies

Both bioavailability and bioequivalence focus on the release of a drug substance from its dosage form and subsequent absorption into the systemic circulation. Bioavailability and Bioequivalence studies are required by regulations to ensure therapeutic equivalence between a pharmaceutically equivalent test product and a reference product. Several in vivo and in vitro methods are used to measure product quality.

 

  • Drug formulations
  • Fixed-dose combination products
  • Manufacturing drugs

Related Conference of Bioequivalence Protocols: In vivo/ In vitro studies

January 19-20, 2026

17th International Conference on Biofuels and Bioenergy

Barcelona, Spain
May 04-05, 2026

7th International Conference on Drug Chemistry

Paris, France
July 23-24, 2026

22nd World Congress on Structural Biology

Aix-en-Provence, France
September 03-04, 2026

16th World Glycobiology Congress

Aix-en-Provence, France
September 21-22, 2026

24th International Conference on Structural Biology

Barcelona, Spain

Bioequivalence Protocols: In vivo/ In vitro studies Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in